Eleven Biotherapeutics, Inc. 4
4 · Eleven Biotherapeutics, Inc. · Filed Feb 27, 2015
Insider Transaction Report
Form 4
Celniker Abbie
DirectorPresident and CEO
Transactions
- Award
Stock Option
2015-02-26+145,000→ 282,795 totalExercise: $10.39Exp: 2025-02-25→ Common Stock (145,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 26, 2015 and vests over four years in equal quarterly installments, with the first installment vesting on March 31, 2015.